ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 2604

$834K Total Retail Price of All Prescriptions

Rank: 38 out of 2604

461 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 461 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 461 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 16,807 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 1,039 988 1 4
HYDROCODONE-ACETAMINOPHEN 590 564 S3 2 1
FUROSEMIDE 588 577 3 8
POTASSIUM CHLORIDE 584 557 4 16
SIMVASTATIN 539 485 5 2
OMEPRAZOLE 443 381 6 5
POLYETHYLENE GLYCOL 3350 420 414 7 42
ATENOLOL 382 377 8 11
AMLODIPINE BESYLATE 363 351 9 6
DONEPEZIL HCL 357 357 10 28
WARFARIN SODIUM 353 342 11 13
METOPROLOL TARTRATE 352 343 12 9
GABAPENTIN 337 327 13 12
SERTRALINE HCL 295 267 14 23
CARVEDILOL 257 228 15 26
LISINOPRIL 253 218 16 3
TRAMADOL HCL 238 229 17 15
NAMENDA 230 230 18 37
RAMIPRIL 230 230 18 111
DIGOXIN 228 228 20 71
ISOSORBIDE MONONITRATE ER 202 188 21 38
DILTIAZEM 24HR CD 194 188 22 124
METOPROLOL SUCCINATE 182 173 23 17
METFORMIN HCL 180 160 24 7
MIRTAZAPINE 167 167 25 52
RANITIDINE HCL 162 140 26 25
ATORVASTATIN CALCIUM 155 154 27 19
ESCITALOPRAM OXALATE 138 134 28 73
GLIMEPIRIDE 135 112 29 57
ALBUTEROL SULFATE 132 132 30 93
FLUTICASONE PROPIONATE 117 105 31 31
FENTANYL 116 113 S2 32 48
QUETIAPINE FUMARATE 110 103 33 66
OXYBUTYNIN CHLORIDE 103 89 34 92
HYDROCHLOROTHIAZIDE 103 75 34 10
DIOVAN 102 102 36 123
TRIAMTERENE-HCTZ 101 100 37 55
MELOXICAM 100 98 38 36
LOSARTAN POTASSIUM 95 92 39 20
LOVASTATIN 95 79 39 24
CIPROFLOXACIN HCL 94 94 41 59
CLOPIDOGREL 88 86 42 39
ALLOPURINOL 88 88 42 35
PREDNISONE 87 83 44 34
TRAZODONE HCL 87 68 44 46
NEXIUM 85 84 46 53
AMOXICILLIN 84 80 47 99
MECLIZINE HCL 82 79 48 155
PANTOPRAZOLE SODIUM 82 77 48 64
SINGULAIR 82 74 48 120
DOXYCYCLINE HYCLATE 81 79 51 122
ROPINIROLE HCL 81 77 51 102
CYCLOBENZAPRINE HCL 80 77 R 53 43
DETROL LA 80 78 53 219
CEPHALEXIN 80 77 53 74
CELEBREX 78 66 56 114
ZOLPIDEM TARTRATE 75 74 57 21
CITALOPRAM HBR 73 72 58 18
LATANOPROST 70 70 59 184
ZETIA 69 61 60 94
CARBIDOPA-LEVODOPA 69 62 60 97
IPRATROPIUM BROMIDE 68 68 62 164
SPIRONOLACTONE 66 66 63 78
TRAVATAN Z 66 66 63 228
OLANZAPINE 66 47 63 115
PLAVIX 64 64 66 75
LANTUS 63 50 67 40
AGGRENOX 62 50 68 206
LAMOTRIGINE 61 41 69 185
LEVOFLOXACIN 61 55 69 113
VENTOLIN HFA 60 51 71 63
RISPERIDONE 60 23 71 65
NOVOLOG 60 40 71 89
LEVETIRACETAM 58 58 74 96
AMIODARONE HCL 58 58 74 239
FORTICAL 56 56 76 318
CYMBALTA 56 56 76 44
LOVAZA 56 48 76 146
TAMSULOSIN HCL 56 56 76 30
HYDROXYZINE HCL 54 54 R 80 214
MUPIROCIN 54 52 80 204
NITROGLYCERIN PATCH 51 51 82 259
SUCRALFATE 51 51 82 209
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.